Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Leukemia
|
April 1, 1997
Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: recent results and future prospects
C Renner, L Trümper, M Pfreundschuh
Leukemia
|
January 1, 1997
Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells
J Schwaller, T Pabst, H P Koeffler, et al.
Leukemia
|
February 20, 2009
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
T Rückrich, M Kraus, J Gogel, et al.
Leukemia
|
October 7, 2006
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
M Kraus, T Rückrich, M Reich, et al.
Leukemia
|
July 6, 2017
Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
A Besse, S C Stolze, L Rasche, et al.
Leukemia
|
April 28, 2016
Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
G P Soriano, L Besse, N Li, et al.
Leukemia
|
August 13, 2014
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
R B Walter, M Othus, A K Burnett, et al.
Leukemia
|
December 7, 2017
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen, P de Lorenzo, M Campbell, et al.
Leukemia
|
July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio
J Versluis, F E M In 't Hout, R Devillier, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Leukemia
|
April 1, 1997
Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: recent results and future prospects
C Renner, L Trümper, M Pfreundschuh
Leukemia
|
January 1, 1997
Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells
J Schwaller, T Pabst, H P Koeffler, et al.
Leukemia
|
February 20, 2009
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
T Rückrich, M Kraus, J Gogel, et al.
Leukemia
|
October 7, 2006
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
M Kraus, T Rückrich, M Reich, et al.
Leukemia
|
July 6, 2017
Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
A Besse, S C Stolze, L Rasche, et al.
Leukemia
|
April 28, 2016
Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
G P Soriano, L Besse, N Li, et al.
Leukemia
|
August 13, 2014
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
R B Walter, M Othus, A K Burnett, et al.
Leukemia
|
December 7, 2017
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen, P de Lorenzo, M Campbell, et al.
Leukemia
|
July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio
J Versluis, F E M In 't Hout, R Devillier, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Page
of 2